Scilex Holding (SCLX) Non-Current Debt (2021 - 2025)
Scilex Holding (SCLX) posted quarterly Non-Current Debt of $22.5 million for Q4 2025, up 2560.36% year-over-year from $845000.0 in Q4 2024, and up 2560.36% quarter-over-quarter from $845000.0 in Q4 2024.
Scilex Holding (SCLX) Non-Current Debt (2021 - 2025) Analysis & Trends
Scilex Holding's Non-Current Debt history runs 5 years deep, the most recent figure standing at $22.5 million for Q4 2025.
- In Q4 2025, Non-Current Debt rose 2560.36% year-over-year to $22.5 million; the TTM figure through Dec 2025 stood at $22.5 million (up 2560.36% YoY), while the FY2025 annual figure was $22.5 million, up 2560.36% from the prior year.
- Non-Current Debt for Q4 2025 stood at $22.5 million, up from $845000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $72.0 million in Q4 2021, with the low at $845000.0 in Q4 2024.
- The 5-year median for Non-Current Debt is $15.3 million (2024), against an average of $18.4 million.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt slumped 95.04% in 2024, then soared 2560.36% in 2025.
- Scilex Holding's Non-Current Debt stood at $72.0 million in 2021, then slumped by 95.87% to $3.0 million in 2022, then jumped by 473.35% to $17.0 million in 2023, then plunged by 95.04% to $845000.0 in 2024, then jumped by 2560.36% to $22.5 million in 2025.
- Business Quant data shows SCLX's Non-Current Debt at $22.5 million in Q4 2025, $845000.0 in Q4 2024, and $14.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.37 Bn | 633.61 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 471.07 Bn | 464.50 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 378.82 Bn | 371.68 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 303.27 Bn | 295.58 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 259.11 Bn | 254.21 Bn | 12.86 Bn | 23.68 Bn |
| 6 | Amgen | 237.62 Bn | 223.63 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 183.34 Bn | 180.16 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 161.05 Bn | 149.36 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Gsk | 106.03 Bn | 101.87 Bn | 8.24 Bn | -18.71 Bn |
| 10 | Scilex Holding | 40.73 Mn | -72.06 Mn | 3.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.48 Mn |
| Dec 31, 2024 | 845,000.00 |
| Sep 30, 2024 | 14.33 Mn |
| Jun 30, 2024 | 29.03 Mn |
| Mar 31, 2024 | 16.32 Mn |
| Dec 31, 2023 | 17.04 Mn |
| Sep 30, 2023 | 6.93 Mn |
| Sep 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Dec 31, 2021 | 72.04 Mn |